DNA Brands, Inc.
DNAX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $80 | $50 | $51 | $63 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80 | $50 | $51 | $63 |
| Operating Income | -$80 | -$50 | -$51 | -$63 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$58 | -$106 | -$57 | -$57 |
| Pre-Tax Income | -$138 | -$156 | -$107 | -$120 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$138 | -$156 | -$107 | -$120 |
| % Margin | – | – | – | – |
| EPS | 0 | -0 | -0 | -0 |
| % Growth | 100% | 0% | 50% | – |
| EPS Diluted | 0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 3,394,795 | 742,754 | 742,754 | 742,754 |
| Weighted Avg Shares Out Dil | 3,394,795 | 742,754 | 742,754 | 742,754 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $58 | $106 | $57 | $57 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$80 | -$50 | -$51 | -$63 |
| % Margin | – | – | – | – |